Avanir Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology - Drugs.com MedNews
Links shared publicly online about this topic.
- 874total visits
Avanir Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology - Drugs.com MedNews
View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 2:17 pm By:
Avanir Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology: AVANIR Pharma... http://bit.ly/bY1VxC #drug
AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website
news-medical.net — “AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or mul” View full resource at news-medical.net
Most Recently Shared on September 15, 2010 at 1:33 pm By:
Stroke News: AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website: AVANIR Ph... http://twurl.nl/tbm68j
AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published In Annals Of Neurology
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/qu” View full resource at medicalnewstoday.com
Most Recently Shared on September 15, 2010 at 1:32 pm By:
AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published In Annals Of Neurology http://mnt.to/3JMb #multiplesclerosis
AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website
news-medical.net — “AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or mul” View full resource at news-medical.net
Most Recently Shared on September 15, 2010 at 1:32 pm By:
AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website: AVANIR Pharmaceuticals, ... http://bit.ly/9H4dAl
Advertisement
